0001418812-11-000032.txt : 20110407
0001418812-11-000032.hdr.sgml : 20110407
20110407184324
ACCESSION NUMBER: 0001418812-11-000032
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20101222
FILED AS OF DATE: 20110407
DATE AS OF CHANGE: 20110407
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morfit G Mason
CENTRAL INDEX KEY: 0001325920
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 11747253
MAIL ADDRESS:
STREET 1: 435 PACIFIC AVENUE
STREET 2: 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94133
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7150 MISSISSAUGA ROAD
STREET 2: MISSISSAUGA
CITY: ONTARIO
STATE: A6
ZIP: 00000
BUSINESS PHONE: 905 286-3000
MAIL ADDRESS:
STREET 1: 7150 MISSISSAUGA ROAD
STREET 2: MISSISSAUGA
CITY: ONTARIO
STATE: A6
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4/A
1
primary_doc.xml
PRIMARY DOCUMENT
X0303
4/A
2010-12-22
2010-12-27
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001325920
Morfit G Mason
435 PACIFIC AVENUE
4TH FLOOR
SAN FRANCISCO
CA
94133
1
0
0
0
Restricted Share Units
2010-12-22
4
A
0
636
0
A
66981
D
Restricted Share Units
2010-12-22
4
A
0
748
0
A
67729
D
Restricted Share Units
2010-12-22
4
A
0
753
0
A
68482
D
Restricted Share Units
2010-12-22
4
A
0
165
0
A
68647
D
Each restricted share unit (RSU) represents a contingent right to receive one share of Common Stock, no par value, of Valeant Pharmaceuticals International, Inc.(the "Common Stock").
Represents dividend equivalents accrued on RSUs as a result of a dividend paid on the Common Stock on December 22, 2010.
This amendment is being filed to correct the number of restricted share units that were reported in the original filing.
Under an agreement with ValueAct Capital, G. Mason Morfit is deemed to hold the restricted share units for the benefit of ValueAct Capital Master Fund, L.P. and indirectly for (i) VA Partners I, LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund, L.P., (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the sole owner of the limited partnership interests of ValueAct Capital Management, L.P. and the membership interests of ValueAct Capital Management, LLC and as the majority owner of the membership interests of VA Partners I, LLC and (v) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P.
Each reporting person listed herein disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
/s/ G. Mason Morfit, Member, VA Partners I, LLC
2011-04-07